
Validea's 'Patient Investor' model, based on Warren Buffett's strategy, rates Lululemon Athletica (LULU) at 79% for its underlying fundamentals and valuation. While LULU demonstrates strong performance across most Buffett criteria, including predictable earnings, low debt, robust returns, and free cash flow, its score falls just below the 80% threshold typically indicating strategic interest, primarily due to a 'Fail' in Initial Rate of Return.
Lululemon Athletica (LULU) exhibits strong fundamental characteristics according to a quantitative model based on Warren Buffett's investment strategy, scoring 79% on Validea's Patient Investor screen. This score places it just below the 80% threshold that typically indicates strategic interest. The company demonstrates robust financial health, passing key tests for earnings predictability, manageable debt service, high return on equity, and strong return on total capital. Furthermore, LULU shows positive signals in its use of retained earnings, free cash flow generation, and share repurchase activity. The primary factor restraining a higher score is a failure on the "Initial Rate of Return" criterion, suggesting that, despite the company's high quality, its current stock valuation may not meet the strict entry-price discipline required by the model. The stock does, however, pass the "Expected Return" test, indicating a more favorable long-term outlook.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment